scispace - formally typeset
Open AccessJournal ArticleDOI

Atypical Hemolytic Uremic Syndrome

TLDR
HUS is a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure that predicts the prognosis both in native kidneys and after renal transplantation.
About
This article is published in Seminars in Nephrology.The article was published on 2013-11-01 and is currently open access. It has received 258 citations till now. The article focuses on the topics: Atypical hemolytic uremic syndrome & Eculizumab.

read more

Citations
More filters
Journal ArticleDOI

Case Report: Benefits and Challenges of Long-term Eculizumab in Atypical Hemolytic Uremic Syndrome

TL;DR: It is recommended that children be vaccinated against invasive meningococcal infection before beginning eculizumab therapy and take appropriate antibiotic prophylaxis during treatment, and it is suggested that vaccine responses should be checked and followed annually.
Journal ArticleDOI

Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?

TL;DR: It is suggested that intraocular rather than systemic modulation of complement may prove more effective in relation to age-related macular degeneration and this has important implications for designing novel complement-based AMD therapies.
Journal ArticleDOI

The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.

TL;DR: Molecular diagnostics has improved the differentiation of acute thrombotic microangiopathys and novel complement mutations and a high incidence of CD46 were identified, with favorable long term outcomes.
Journal ArticleDOI

Biophysical analysis of sialic acid recognition by the complement regulator Factor H.

TL;DR: This work characterized FH’s sialylation with respect to glycosidic linkage type and searched for further potential sialic acid binding sites in FH and its seven-domain spanning splice variant and fellow complement regulator FH like-1 (FHL-1), and probed FH binding to the sIALic acid variant Neu5Gc.
References
More filters
Journal ArticleDOI

Complement: a key system for immune surveillance and homeostasis

TL;DR: An updated view of the function, structure and dynamics of the complement network is described, its interconnection with immunity at large and with other endogenous pathways is highlighted, and its multiple roles in homeostasis and disease are illustrated.
Journal ArticleDOI

Atypical Hemolytic–Uremic Syndrome

TL;DR: Current concepts about the pathobiology of atypical hemolytic–uremic syndrome are reviewed and its diagnosis and management are reviewed.
Journal ArticleDOI

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

TL;DR: The recent approval of eculizumab as a first-in-class complement inhibitor for the treatment of PNH validates the concept of complement inhibition as an effective therapy and provides rationale for investigation of other indications in which complement plays a role.
Related Papers (5)